HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Orthox Closes $12.5m Series A Financing
Nick Skaer, co-founder, and CEO of Orthox said: "This $12.5m Series A financing round from a range of high-quality medtech investors reflects the strong progress we are making with our award-winning FibroFix product platform.
CroíValve Raises an €8M Series A Round
The funding will support a European Feasibility Study of the CroíValve Transcatheter Tricuspid DUO Coaptation Valve System.
Damae Medical Raises €5M in Series A Financing
The financial resources offered by this second round of financing of €5 million will enable the company to accelerate the commercial deployment of deepLive™ in Europe and to push the development of our product even further.
Enable Injections Announces $215 Million in Series C Financing
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.
NaoX Technologies Raises €4.3 Million
NaoX was co-founded in 2018 by Hugo Dinh, a graduate from Ecole Polytechnique, and Michel Le Van Quyen, a research director at Inserm, respectively CEO and Chief Scientific Officer.
SetBone Medical Announces $1.6 Million Financing
The funds raised will support the next stage of development and initiation of a First in Human pilot study.
PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving Mask
Prevail Partners, LLC, an affiliate of InfoWorks, has agreed to invest significantly in PolyPhotonix upon the commencement of the FDA clinical trial as lead investor in a $10M Series A investment round. Successful completion of the FDA clinical trial will open the US market to the treatment.
ENPICOM Secures Series B Funding
BOP Capital leads investment round supported by ENPICOM’s existing investors
Akura Medical, A New Shifamed Portfolio Company, Closes $25M in an Oversubscribed Series A1 Financing
The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.